These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 27544574)

  • 1. Skeletal muscle-specific overexpression of IGFBP-2 promotes a slower muscle phenotype in healthy but not dystrophic mdx mice and does not affect the dystrophic pathology.
    Swiderski K; Martins KJ; Chee A; Trieu J; Naim T; Gehrig SM; Baum DM; Brenmoehl J; Chau L; Koopman R; Gregorevic P; Metzger F; Hoeflich A; Lynch GS
    Growth Horm IGF Res; 2016; 30-31():1-10. PubMed ID: 27544574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of insulin-like growth factor (IGF)-I and IGF-binding protein interactions enhances skeletal muscle regeneration and ameliorates the dystrophic pathology in mdx mice.
    Schertzer JD; Gehrig SM; Ryall JG; Lynch GS
    Am J Pathol; 2007 Oct; 171(4):1180-8. PubMed ID: 17823291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable micro-dystrophin gene transfer using an integrating adeno-retroviral hybrid vector ameliorates the dystrophic pathology in mdx mouse muscle.
    Roberts ML; Wells DJ; Graham IR; Fabb SA; Hill VJ; Duisit G; Yuasa K; Takeda S; Cosset FL; Dickson G
    Hum Mol Genet; 2002 Jul; 11(15):1719-30. PubMed ID: 12095914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice.
    Schertzer JD; Ryall JG; Lynch GS
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E499-505. PubMed ID: 16621899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of PEGylated insulin-like growth factor I for skeletal muscle disease evaluated in two murine models of muscular dystrophy.
    Gehrig SM; van der Poel C; Hoeflich A; Naim T; Lynch GS; Metzger F
    Growth Horm IGF Res; 2012 Apr; 22(2):69-75. PubMed ID: 22424862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of Galgt2 (B4Galnt2) reduces muscle growth in response to acute injury and increases muscle inflammation and pathology in dystrophin-deficient mice.
    Xu R; Singhal N; Serinagaoglu Y; Chandrasekharan K; Joshi M; Bauer JA; Janssen PM; Martin PT
    Am J Pathol; 2015 Oct; 185(10):2668-84. PubMed ID: 26435413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striated muscle activator of Rho signalling (STARS) overexpression in the mdx mouse enhances muscle functional capacity and regulates the actin cytoskeleton and oxidative phosphorylation pathways.
    Sadler KJ; Gatta PAD; Naim T; Wallace MA; Lee A; Zaw T; Lindsay A; Chung RS; Bello L; Pegoraro E; Lamon S; Lynch GS; Russell AP
    Exp Physiol; 2021 Jul; 106(7):1597-1611. PubMed ID: 33963617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy.
    Morales MG; Gutierrez J; Cabello-Verrugio C; Cabrera D; Lipson KE; Goldschmeding R; Brandan E
    Hum Mol Genet; 2013 Dec; 22(24):4938-51. PubMed ID: 23904456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGF-II ameliorates the dystrophic phenotype and coordinately down-regulates programmed cell death.
    Smith J; Goldsmith C; Ward A; LeDieu R
    Cell Death Differ; 2000 Nov; 7(11):1109-18. PubMed ID: 11139285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TIPE2 gene transfer with adeno-associated virus 9 ameliorates dystrophic pathology in mdx mice.
    Gao S; Lu A; Amra S; Guo P; Huard J
    Hum Mol Genet; 2019 May; 28(10):1608-1619. PubMed ID: 30608588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipin1 plays complementary roles in myofibre stability and regeneration in dystrophic muscles.
    Jama A; Alshudukhi AA; Burke S; Dong L; Kamau JK; Voss AA; Ren H
    J Physiol; 2023 Mar; 601(5):961-978. PubMed ID: 36715084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BGP-15 Improves Aspects of the Dystrophic Pathology in mdx and dko Mice with Differing Efficacies in Heart and Skeletal Muscle.
    Kennedy TL; Swiderski K; Murphy KT; Gehrig SM; Curl CL; Chandramouli C; Febbraio MA; Delbridge LM; Koopman R; Lynch GS
    Am J Pathol; 2016 Dec; 186(12):3246-3260. PubMed ID: 27750047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In dystrophic
    Debruin D; McRae NL; Addinsall AB; McCulloch DR; Barker RG; Debrincat D; Hayes A; Murphy RM; Stupka N
    Am J Physiol Cell Physiol; 2024 Oct; 327(4):C1035-C1050. PubMed ID: 39159389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapamycin ameliorates dystrophic phenotype in mdx mouse skeletal muscle.
    Eghtesad S; Jhunjhunwala S; Little SR; Clemens PR
    Mol Med; 2011; 17(9-10):917-24. PubMed ID: 21607286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle-specific overexpression of IGF-I improves E-C coupling in skeletal muscle fibers from dystrophic mdx mice.
    Schertzer JD; van der Poel C; Shavlakadze T; Grounds MD; Lynch GS
    Am J Physiol Cell Physiol; 2008 Jan; 294(1):C161-8. PubMed ID: 17989207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A GDF11/myostatin inhibitor, GDF11 propeptide-Fc, increases skeletal muscle mass and improves muscle strength in dystrophic mdx mice.
    Jin Q; Qiao C; Li J; Xiao B; Li J; Xiao X
    Skelet Muscle; 2019 May; 9(1):16. PubMed ID: 31133057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
    Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
    J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Klotho gene silencing promotes pathology in the mdx mouse model of Duchenne muscular dystrophy.
    Wehling-Henricks M; Li Z; Lindsey C; Wang Y; Welc SS; Ramos JN; Khanlou N; Kuro-O M; Tidball JG
    Hum Mol Genet; 2016 Jun; 25(12):2465-2482. PubMed ID: 27154199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase-2 ablation in dystrophin-deficient mdx muscles reduces angiogenesis resulting in impaired growth of regenerated muscle fibers.
    Miyazaki D; Nakamura A; Fukushima K; Yoshida K; Takeda S; Ikeda S
    Hum Mol Genet; 2011 May; 20(9):1787-99. PubMed ID: 21320869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.